Overview

  • Product nameOuabain octahydrate
  • Description
    Na+/K+ ATPase inhibitor
  • Biological descriptionNa+/K+ ATPase inhibitor (Ki = 30 μM). Cardiac glycoside. Stimulates activity at low nanomolar concentrations in rats. Improves cardiac function in myocardial infarction rats. Centrally active following oral administration.
  • Purity> 98%
  • General notes

    It has been reported that an aqueous solution of this material stored overnight in a borosilicate glass vial leads to the formation of ouabain-borate complexes.
    It is therefore recommended that this material is stored in a plastic vial and any contact with borosilicate glass is minimised.

Properties

    References for Ouabain octahydrate (ab120748)

    This product has been referenced in:
    • Nelissen-Vrancken HJ  et al. Ouabain improves cardiac function in vivo in rats with heart failure after chronic but not acute treatment. Naunyn Schmiedebergs Arch Pharmacol 356:203-9 (1997). Read more (PubMed: 9272726) »
    • Blaustein MP Endogenous ouabain: role in the pathogenesis of hypertension. Kidney Int 49:1748-53 (1996). Read more (PubMed: 8743490) »
    • Huang BS  et al. Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats. Hypertension 23:1087-90 (1994). Read more (PubMed: 7911450) »
    • Hara Y  et al. Expression of active alpha-3 subunit of rat brain Na+,K+-ATPase from the messenger RNA injected into Xenopus oocytes. Biochem Biophys Res Commun 163:102-5 (1989). Read more (PubMed: 2549984) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120748.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"